Trials / Completed
CompletedNCT03597659
PheWAS of a Polygenic Predictor of Thyroid Function
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 37,154 (actual)
- Sponsor
- Groupe Hospitalier Pitie-Salpetriere · Academic / Other
- Sex
- All
- Age
- 28 Years – 100 Years
- Healthy volunteers
- Accepted
Summary
Performing a phenome-wide association study (PheWAS) identifying clinical diagnoses associated with a polygenic predictor of Thyroid stimulating hormone (TSH) levels identified by a previously published genome-wide association study (GWAS). PheWAS will be applied in an electronic-health-record (EHR) cohort including North American (n: 37,154) and European participants using 1,318 phenotypes.
Detailed description
Applying a genetic predictor of thyroid stimulating hormone levels to an electronic-health-record cohort to verify associations with thyroid disorders as positive controls, and identify new associations .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | phenome-wide association study (PheWAS) | Phenome-wide association study (PheWAS) identifying clinical diagnoses associated with a polygenic predictor of TSH levels identified by a previously published genome-wide association study (GWAS) which included North American and European participants. A phenome-wide scanning of 1,318 phenotypes will be performed, using a cohort of 37,154 North American individuals of European ancestry with electronic-health-record (EHR) data. |
Timeline
- Start date
- 2017-09-01
- Primary completion
- 2018-07-01
- Completion
- 2018-07-01
- First posted
- 2018-07-24
- Last updated
- 2019-09-26
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03597659. Inclusion in this directory is not an endorsement.